Eisai Company, Ltd. Launches “Nitorol(R) Injection 5 mg Syringe” and “Nitorol(R) Continuous Intravenous Infusion 25 mg Syringe”, First Nitric Acid Syringe Formulations Approved in Japan

Tokyo, July 11, 2007 (JCN Newswire) - Eisai Co., Ltd. announced the launch of “Nitorol(R) Injection 5 mg Syringe” and “Nitorol(R) Continuous Intravenous Infusion 25 mg Syringe” (generic name: isosorbide dinitrate), the first nitric acid syringe formulations approved for the treatment of acute cardiac failure and unstable angina in Japan. The new formulations will be available from July 12, 2007.

MORE ON THIS TOPIC